Malignant Solid Neoplasm — Trials

Malignant Solid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

900 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 429
Recruiting: 209
Ph III recruiting: 10
Growth YoY: +2.3%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (101)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04745910	Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome	completed	Phase 4	10	M.D. Anderson Cancer CenterOTHER	1	May 6, 2026	clinicaltrials
NCT05054998	Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases	completed	Phase 4	12	M.D. Anderson Cancer CenterOTHER	1	May 1, 2024	clinicaltrials